Brief: Armata Pharma Reports Q4 And Full Year 2021 Results
17/03/2022 20:14
March 17 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL
YEAR
2021 RESULTS AND PROVIDES CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $0.23
* ARMATA PHARMACEUTICALS INC SAYS QTRLY GRANT REVENUES
$989,000
VERSUS $504,000
Source text for Eikon: ID:nPn6JCWhZa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles